ARCHIVES

DCT Advisors Approve Recompetition Of Drug Discovery Groups

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Outstanding Investigator Awards Draw 150 Letters Of Intent; Applications Due July 15

June 15, 1984

In Brief: Pay raise Must Come From Intramural Funds, Not Extramural, Administration Says

May 9, 1980

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

NCAB Approves Plan for Public Participation Hearings Around U.S.

February 20, 1987